Skip to main navigation Skip to search Skip to main content

A Phase 3, Multicenter, Four Week, Randomized Double Blind, Placebo Controlled, Parallel Group Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents with Bipolar I Disorder

Project: Research

Project Details

StatusFinished
Effective start/end date09/18/1409/17/18

Funding

  • ICON Clinical Research: $5,059.00